FDA Puts Brakes on OTC Cialis Trial

Published on May 30, 2022

The FDA has hit the brakes on a trial aimed at assessing the possibility of making Cialis, a prescription drug for erectile dysfunction, available over-the-counter (OTC). This setback means that for now, Cialis will remain a prescription-only treatment. It’s like when you plan to go for a joyride but your parents suddenly slam on the car brakes before you can even start the engine! The FDA wants to take more time to evaluate the safety and effectiveness of an OTC version of Cialis, which requires careful scrutiny. This decision is understandable since making potent drugs like Cialis available without a prescription could have serious health consequences if misused. It’s important to ensure that patients have access to safe and effective treatments without compromising their well-being. To learn more about this pivotal trial and stay updated on any future developments, check out the underlying research.

The U.S. health regulator has put on hold a trial designed to evaluate switching the prescription-only erectile dysfunction drug Cialis to an over-the-counter (OTC) treatment, French drugmaker Sanofi said Monday.

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>